Schonfeld Strategic Advisors LLC - Jun 30, 2025 SCHEDULE 13G/A Report for Fate Therapeutics, Inc. Common Stock, par value $0.001 per share (FATE)

Filing Manager: Schonfeld Strategic Advisors LLC
Reporting Manager: Schonfeld Strategic Advisors LLC
Security: Fate Therapeutics, Inc. Common Stock, par value $0.001 per share
Symbol: FATE
Shares outstanding: 114M shares
Disclosed Ownership: 938K shares
Ownership: 0.82%
Form type: SCHEDULE 13G/A
Date filed: 8/14/2025, 04:30 PM
Date of event: Jun 30, 2025
Previous filing: May 15, 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Schonfeld Strategic Advisors LLC	0.82%	938K	938K	0	/s/ Hung Luc	Hung Luc, Chief Compliance Officer